NYSE - Nasdaq Real Time Price USD

Bristol-Myers Squibb Company (BMY)

Time to buy BMY?

47.62

+0.05

+(0.11%)

At close: May 7 at 4:00:02 PM EDT

46.77

-0.85

(-1.78%)

Pre-Market: 9:09:49 AM EDT

Time to buy BMY?

The Zacks Analyst Blog Highlights Verizon Communications, Bristol-Myers Squibb, Canadian Pacific and Nova LifeStyle

Verizon Communications, Bristol-Myers Squibb, Canadian Pacific and Nova LifeStyle are part of the Zacks top Analyst Blog.

Zacks 3 hours ago

CP

CELG-RT

VZ
Top Research Reports for Verizon Communications, Bristol-Myers Squibb & Canadian Pacific

Today's Research Daily features new research reports on 16 major stocks, including Verizon Communications Inc. (VZ), Bristol-Myers Squibb Co. (BMY) and Canadian Pacific Kansas City Ltd. (CP), as well a micro-cap stock Nova LifeStyle, Inc. (NVFY).

Zacks 15 hours ago

CP

CELG-RT

VZ
Improving Access to Care by Strengthening Local Health System Capacity

NORTHAMPTON, MA / ACCESS Newswire / May 7, 2025 / By Catharine Grimes, President of the Bristol Myers Squibb Foundation We are in an era of unprecedented medical innovation. Scientists are making remarkable progress to diagnose and treat diseases, ...

ACCESS Newswire 23 hours ago

BMY
+0.11%

CELG-RT
Bristol-Myers Squibb (NYSE:BMY) Appoints Cari Gallman As New General Counsel

Bristol-Myers Squibb (NYSE:BMY) recently appointed Cari Gallman as the new Executive Vice President, General Counsel, and Chief Policy Officer following Sandra Leung’s retirement. This leadership change might have influenced investors' outlook on the company, contributing to a 3% increase in share price over the last week. However, this movement aligns with the overall market trend, which saw a rise of 2%. Moreover, broader market dynamics, including investor focus on impending Federal...

Simply Wall St. yesterday

BMY
+0.11%

CELG-RT
Bristol Myers Squibb announces $40bn US investment plan over five years

The funds will reportedly be allocated for R&D, technology advancements, and enhancing domestic manufacturing capacity.

Pharmaceutical Technology 2 days ago

CELG-RT

GLDAF
Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer

PRINCETON, N.J., May 06, 2025--Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer

Business Wire 2 days ago

BMY
+0.11%

CELG-RT
Elanco (ELAN) Reports Q1: Everything You Need To Know Ahead Of Earnings

Animal health company Elanco (NYSE:ELAN) will be reporting results tomorrow before market hours. Here’s what to look for.

StockStory 2 days ago

ELAN

CELG-RT
Bristol Myers to invest $40 billion in the US over 5 years

The announcement of new investment was first made by CEO Christopher Boerner in an opinion piece published in Stat News on Monday, and was later confirmed to Reuters by a company spokesperson. In the Op-Ed, Boerner said the money will be spread across research and development, technology and domestic manufacturing, as U.S. drugmakers prepare to deal with Trump's tariffs. Trump has repeatedly threatened tariffs on pharmaceutical imports on national security grounds.

Reuters 2 days ago

CELG-RT
Was Jim Cramer Right About Bristol-Myers Squibb Company (BMY)?

We recently published a list of Did Jim Cramer Hit or Miss On These 13 Stock Predictions? In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other stocks that Jim Cramer discussed during the episode of Mad Money on May 1st, 2024. During the Mad Money episode […]

Insider Monkey 2 days ago

CELG-RT
Supernus Pharmaceuticals Earnings: What To Look For From SUPN

Specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) will be reporting earnings tomorrow after market close. Here’s what to look for.

StockStory 3 days ago

SUPN

CELG-RT
1 Stock Under $50 with Solid Fundamentals and 2 to Keep Off Your Radar

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.

StockStory 6 days ago

CELG-RT

BRZE
Jim Cramer Says He Likes Bristol-Myers Squibb (BMY) More Than Merck Due to Schizophrenia Drug

We recently published a list of 10 Jim Cramer Stocks to Watch Amid Trump Tariff Wars. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other stocks that Jim Cramer discussed. Jim Cramer in a latest program on CNBC talked about the latest signs of de-escalation […]

Insider Monkey 6 days ago

CELG-RT
Bristol-Myers Squibb's (NYSE:BMY) Strong Earnings Are Of Good Quality

Bristol-Myers Squibb Company ( NYSE:BMY ) just reported healthy earnings but the stock price didn't move much. We think...

Simply Wall St. 7 days ago

BMY
+0.11%

CELG-RT
Is Bristol-Myers Squibb Company (BMY) the Best Long-Term Dividend Stock to Buy According to Billionaires?

We recently published a list of the 10 Best Long-Term Dividend Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best long-term dividend stocks. Dividend stocks are increasingly popular with both every day and billionaire investors. A CNBC report […]

Insider Monkey 8 days ago

CELG-RT
Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock

Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks 9 days ago

CELG-RT
Jim Cramer is Recommending This Dividend Stock With 5% Yield for ‘Good Protection’

We recently published a list of 10 Stocks to Watch as Trade Wars Begin. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other stocks to watch as trade wars begin. Bill Strazzullo, Bell Curve Trading chief market strategist, said in a latest program on CNBC […]

Insider Monkey 9 days ago

CELG-RT

^GSPC
BMSCH announces Children’s Same Day Services centre in the US

The facility is designed to offer private care for children requiring regular, non-oncologic infusion therapies.

Hospital Management 9 days ago

CELG-RT
BMY Falls 4% Post Q1 Earnings: Should You Buy, Sell or Hold the Stock?

Bristol Myers' first-quarter performance and raised annual guidance are encouraging. However, we recommend investors to stay on the sidelines as generic competition for legacy drugs and recent pipeline setbacks weigh on the stock.

Zacks 9 days ago

CELG-RT
4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off

It's always a good time to buy solid dividend stocks, but considering the challenging economic environment, now might be a particularly opportune time. With a volatile equity market and a potential recession looming due to the impact of tariffs, dividend stocks can help strengthen any portfolio. With that as a backdrop, let's consider four excellent income stocks that investors can buy amid the current sell-off: AbbVie (NYSE: ABBV), Amgen (NASDAQ: AMGN), Bristol Myers Squibb (NYSE: BMY), and Zoetis (NYSE: ZTS).

Motley Fool 11 days ago

ABBV

ZTS

AMGN
Bristol-Myers Squibb First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Bristol-Myers Squibb ( NYSE:BMY ) First Quarter 2025 Results Key Financial Results Revenue: US$11.2b (down 5.6% from 1Q...

Simply Wall St. 12 days ago

BMY
+0.11%

CELG-RT

Performance Overview

Return	BMY	S&P 500 (^GSPC)
YTD	-13.95%	-4.26%
1-Year	+13.44%	+8.55%
3-Year	-29.93%	+36.57%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Bristol-Myers Squibb Company (BMY)

The Zacks Analyst Blog Highlights Verizon Communications, Bristol-Myers Squibb, Canadian Pacific and Nova LifeStyle

Top Research Reports for Verizon Communications, Bristol-Myers Squibb & Canadian Pacific

Improving Access to Care by Strengthening Local Health System Capacity

Bristol-Myers Squibb (NYSE:BMY) Appoints Cari Gallman As New General Counsel

Bristol Myers Squibb announces $40bn US investment plan over five years

Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer

Elanco (ELAN) Reports Q1: Everything You Need To Know Ahead Of Earnings

Bristol Myers to invest $40 billion in the US over 5 years

Was Jim Cramer Right About Bristol-Myers Squibb Company (BMY)?

Supernus Pharmaceuticals Earnings: What To Look For From SUPN

1 Stock Under $50 with Solid Fundamentals and 2 to Keep Off Your Radar

Jim Cramer Says He Likes Bristol-Myers Squibb (BMY) More Than Merck Due to Schizophrenia Drug

Bristol-Myers Squibb's (NYSE:BMY) Strong Earnings Are Of Good Quality

Is Bristol-Myers Squibb Company (BMY) the Best Long-Term Dividend Stock to Buy According to Billionaires?

Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock

Jim Cramer is Recommending This Dividend Stock With 5% Yield for ‘Good Protection’

BMSCH announces Children’s Same Day Services centre in the US

BMY Falls 4% Post Q1 Earnings: Should You Buy, Sell or Hold the Stock?

4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off

Bristol-Myers Squibb First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Performance Overview